Noema Pharma to Present Phase 2a Results for Cendifensine in Vasomotor Symptoms (Hot Flashes) Due to Menopause at the 2026 ACOG Annual Clinical & Scientific Meeting
Basel, Switzerland and Boston MA – May 1, 2026 – Noema Pharma AG today announced the presentation of Phase 2a study results evaluating cendifensine in menopausal women experiencing moderate-to-severe vasomotor symptoms (VMS) in a poster at the 2026 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting, to be held May 1–3 […]